SCHEMBL6184983

SCHEMBL6184983

CC(=O)On1ccc(-c2cccs2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
TDP1 Q9NUW8 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.45
FYN P06241 5/20 0.44
KDM4E B2RXH2 4/20 0.43
NPC1 O15118 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
HPGD P15428 1/20 0.40
MCL1 Q07820 1/20 0.40
BAZ2B Q9UIF8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5646701 0.79 KMT2A (0.49) KMT2AL3MBTL1TDP1SMN1; SMN2FYN
SCHEMBL5647954 0.79 SMN1; SMN2 (0.46) KMT2AL3MBTL1TDP1SMN1; SMN2FYN
SCHEMBL6628325 0.78 KMT2A (0.44) KMT2AL3MBTL1TDP1SMN1; SMN2KDM4E
SCHEMBL5648637 0.77 NPC1 (0.48) KMT2AL3MBTL1TDP1SMN1; SMN2KDM4E
SCHEMBL8814512 0.76 L3MBTL1 (0.47) KMT2AL3MBTL1TDP1SMN1; SMN2FYN
SCHEMBL8814501 0.75 KMT2A (0.46) KMT2AL3MBTL1TDP1SMN1; SMN2FYN
SCHEMBL9385111 0.72 KMT2A (0.51) KMT2AL3MBTL1TDP1SMN1; SMN2FYN
SCHEMBL5651082 0.72 SMN1; SMN2 (0.51) KMT2AL3MBTL1TDP1SMN1; SMN2KDM4E
SCHEMBL5648675 0.71 KMT2A (0.54) KMT2AL3MBTL1TDP1SMN1; SMN2FYN
SCHEMBL28901178 0.69 PLAU (0.38) KMT2AL3MBTL1SMN1; SMN2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1732161-A 1,3-diamino-2-hydroxypropane pro-drug derivatives ELAN PHARM INC (US) 2006-02-08 CN claimed
EP-1534693-A2 1, 3-DIAMINO-2-HYDROXYPROPANE PRODRUG DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2005-06-01 EP claimed
WO-2004022523-A2 1, 3-DIAMINO-2-HYDROXYPROPANE PRODRUG DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2004-03-18 WO claimed
CN-1732161-A 1,3-diamino-2-hydroxypropane pro-drug derivatives ELAN PHARM INC (US) 2006-02-08 CN disclosed